Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...

Other symptoms of multiple myeloma include the following: Anemia: The overgrowth of myeloma cells in the bone marrow ...

Fractures. About 80% of people with myeloma will have a broken bone caused by myeloma. ... These types of biopsies are most often used to help diagnose multiple myeloma: Bone marrow biopsy.

They may also assess for any bone fractures or breaks since multiple myeloma cancer cells can weaken bones, increasing the ...

Celltrion USA today announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing PROLIA® ...

Multiple myeloma bone lesions occur when cancerous cells cause the bones to form weak spots, ... a doctor may insert rods or plates into the fracture to support fragile and weakened bones.

Diagnosis also required -- and still does -- the presence of at least 10% infiltration of clonal plasma cells on bone marrow examination or a biopsy-proven bony or extramedullary plasmacytoma ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, ... These tumors destroy intricate bone scaffolding, causing bone pain, fractures, ...

Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

New innovative local treatment for osteolytic bone disease in multiple myeloma Date: January 14, 2025 Source: Vrije Universiteit Brussel Summary: A team of researchers has developed a new ...

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

Bone disease is a hallmark of multiple myeloma (MM), associated with bone pain, pathological fractures requiring surgery and/or radiation to bone, spinal cord compression and hypercalcemia. It ...